Evaluation of SARS-CoV-2 in Tears of Patients with Moderate to Severe COVID-19
Top Cited Papers
- 1 April 2021
- journal article
- research article
- Published by Elsevier BV in Ophthalmology
- Vol. 128 (4), 494-503
- https://doi.org/10.1016/j.ophtha.2020.08.029
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease InhibitorCell, 2020
- No Time for TearsOphthalmology, 2020
- Assessing Viral Shedding and Infectivity of Tears in Coronavirus Disease 2019 (COVID-19) PatientsOphthalmology, 2020
- SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected PatientsNew England Journal of Medicine, 2020
- There may be virus in conjunctival secretion of patients with COVID‐19Acta Ophthalmologica, 2020
- Can the Coronavirus Disease 2019 (COVID-19) Affect the Eyes? A Review of Coronaviruses and Ocular Implications in Humans and AnimalsOcular Immunology and Inflammation, 2020
- Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS‐CoV‐2 infectionJournal of Medical Virology, 2020
- Enteric involvement of coronaviruses: is faecal–oral transmission of SARS-CoV-2 possible?The Lancet Gastroenterology & Hepatology, 2020
- 2019-nCoV transmission through the ocular surface must not be ignoredThe Lancet, 2020
- Coronavirus Diversity, Phylogeny and Interspecies JumpingExperimental Biology and Medicine, 2009